The role of combichem in antibiotic discovery

Current Opinion in Microbiology

Volumn 4, Issue 5, 2001, Pages 520-525

  Trias, Joaquim ^a  

^a Versicor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINONIN; ANTIBIOTIC AGENT; ENZYME INHIBITOR; N (1 TERT BUTYL 2 DIMETHYLAMINO 2 OXOETHYL) 2 (N FORMYL N HYDROXYAMINOMETHYL)HEXANAMIDE; OXAZOLIDINONE DERIVATIVE; PEPTIDE LIBRARY; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; VRC 3375;

ANTIBIOTIC SENSITIVITY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; PHARMACOPHORE; REVIEW;

EID: 0034792726     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(00)00245-9     Document Type: Review

References (44)

1. Comprehensive survey of combinatorial library synthesis: 1998
2. Comprehensive survey of combinatorial library synthesis: 1999
3. Synthetic combinatorial libraries; novel discovery strategy for identification of antimicrobial agents
4. Recent advances in the preparation of heterocycles on solid support; a review of the literature
5. Solution- and solid-phase strategies for the design, synthesis, and screening of libraries based on natural product templates: A comprehensive survey of combinatorial library synthesis: 1998
6. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions
7. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries
8. The role of antimicrobial peptides in animal defenses
9. Cationic antimicrobial peptides: Towards clinical applications
10. Identification of antimicrobial peptides by using combinatorial libraries made up of unnatural amino acids
11. Screening for novel antimicrobials from encoded combinatorial libraries by using a two-dimensional agar format
12. Synthetic combinatorial libraries: An emerging approach toward the identification of novel antibiotics
13. Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry
14. Characterization of novel antimicrobial peptoids
15. Combinatorial discovery process yields antimicrobial peptoids
16. Combinatorial libraries: A tool to design antimicrobial and antifungal peptide analogues having lyric specificities for structure-activity relationship studies
17. Synthesis of novel unnatural amino acid as a building block and its incorporation into an antimicrobial peptide
18. Solid-phase synthesis of beta-lactams via the ester enolate-imine condensation route
19. A simple, inexpensive apparatus for performance of preparative scale solution phase multiple parallel synthesis of drug analogs. I. Preparation of a retrospective library of quinolone anti-infective agents
20. A simple, inexpensive apparatus for performance of preparative scale solution phase multiple parallel synthesis of drug analogs. II. Biological evaluation of a retrospective library of quinolone antiinfective agents
21. Novel antifungals based on 4-substituted imidazole: Solid-phase synthesis of substituted aryl sulfonamides towards optimization of in vitro activity
22. Novel antifungals based on 4-substituted imidazole: A combinatorial chemistry approach to lead discovery and optimization
23. Combinatorial lead discovery and optimization of antimicrobial oxazolidinones
24. A solid-phase approach to analogues of the antibiotic mureidomycin
25. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: Inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli
26. Moenomycin, an inhibitor of cell wall synthesis
27. A simple screen for murein transglycosylase inhibitors
28. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis
29. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase
30. Discovery of novel disaccharide antibacterial agents using a combinatorial library approach
31. Peptide deformylase: A new type of mononuclear iron protein
32. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor
33. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor
34. In vivo evaluation of VRC3375, a potent peptide deformylase inhibitor
35. Discovery of a novel gyrase inhibitor by combinatorial solid phase synthesis of 1,2,3,4-tetrahydro-β-carbolines
36. Site-directed ligand discovery
37. Simple selection criteria for drug-like chemical matter
38. Harnessing the power of the genome in the search for new antibiotics
39. Recent developments in structure-based drug design
40. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel 'unnatural' natural products
41. Peptide deformylase as a target for new generation, broad-spectrum antimicrobial agents
42. H-phosphonate derivatives as novel peptide deformylase inhibitors
43. Synthesis and antibacterial activity of peptide deformylase inhibitors
44. Identification of a potent peptide deformylase inhibitor from a rationally designed combinatorial library